AdaptHealth Corp. (AHCO)
NASDAQ: AHCO · Real-Time Price · USD
10.16
+0.06 (0.59%)
At close: Jun 12, 2026, 4:00 PM EDT
10.30
+0.14 (1.38%)
After-hours: Jun 12, 2026, 7:56 PM EDT

AdaptHealth Stock Forecast

Stock Price Forecast

According to 8 analysts polled by S&P Global, AdaptHealth stock has a consensus rating of "Buy" and an average price target of $14. The average 1-year stock price forecast is 37.80% higher than the current stock price, while the lowest is $11 (+8.27%) and the highest is $18 (+77.17%).

Price Target: $14 (+37.80%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$11$14$14$18
Change+8.27%+37.80%+37.80%+77.17%
* Price targets were last updated on May 8, 2026.

Analyst Ratings

The average analyst rating for AdaptHealth stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingJan '26Feb '26Mar '26Apr '26May '26Jun '26
Strong Buy555555
Buy111111
Hold222222
Sell000000
Strong Sell000000
Total888888

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
RBC Capital
RBC Capital
Buy
Maintains
$13$15
BuyMaintains$13$15+47.64%May 8, 2026
Robert W. Baird
Robert W. Baird
Buy
Maintains
$17$18
BuyMaintains$17$18+77.17%May 7, 2026
Canaccord Genuity
Canaccord Genuity
Buy
Maintains
$14$16
BuyMaintains$14$16+57.48%May 7, 2026
UBS
UBS
Buy
Maintains
$15$14
BuyMaintains$15$14+37.80%May 7, 2026
Truist Financial
Truist Financial
Buy
Reiterates
$14
BuyReiterates$14+37.80%May 6, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
3.49B
from 3.24B
Increased by 7.48%
Revenue Next Year
3.71B
from 3.49B
Increased by 6.46%
EPS This Year
0.84
from 0.54
Increased by 54.89%
EPS Next Year
1.18
from 0.84
Increased by 39.86%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
2.47B2.97B3.20B3.26B3.24B3.49B
Revenue Growth
130.24%20.51%7.73%1.90%-0.49%7.48%
Gross Profit
524.54M634.32M681.77M749.16M677.93M760.24M
Gross Margin
21.28%21.35%21.30%22.97%20.89%21.80%
Operating Income
225.61M216.11M278.53M288.25M204.57M255.48M
Net Income
156.18M69.32M-678.90M90.42M-70.79M107.22M
EPS
----0.540.84
EPS Growth
-----44.55%54.89%
Forward PE
15.3615.299.869.9111.6012.08
Free Cash Flow
-43.97M2.37M187.78M166.32M246.52M178.30M
No. Analysts
-----8
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High3.5B
Avg3.5B
Low3.4B

Revenue Growth

Revenue Growth202620272028
High
8.0%
Avg
7.5%
Low
6.3%

EPS Forecast

EPS202620272028
High-
Avg0.84
Low-

EPS Growth

EPS Growth202620272028
High-
Avg
54.9%
Low-